|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1800 CONCORD PIKE, P.O. BOX 15437 |
Address2 |
|
| City | WILMINGTON |
State | DE |
Zip Code | 19850-5437 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 54073-12
|
||||||||
|
6. House ID# 349750000
|
||||||||
| TYPE OF REPORT | 8. Year | 2026 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Katie Jones |
Date | 7/20/2026 1:24:31 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S 1637 MVP Act and Medicaid VBPs for Patients
S 2903 / HR 5509 Safe Step Act
HR 946/S 1862, Optimizing Research Progress Hope and New Cures (ORPHAN Cures) Act
HR 3521 / S 4440 Clinical Trial Modernization Act
HR 7118 Genomic Answers for Childrens Health Act
Clinical Trials Modernization Act
CMMI GENEROUS Demo
FDA modernization policy
Implementation of the Inflation Reduction Act (IRA) -- with specific focus on drug negotiation (orphan drug exemption language)
BIOSECURE Act implementation
Issues related to the Medicare title in the One Big Beautiful Bill Act
Issues related to the IRA definition of a drug for purposes of price negotiation selection
Duplicate discounts as required by IRA
Issues related to expanding/amending the orphan drug exclusion in IRA
Issues related to pharmacy benefit manager (PBM) reform
Issues related to mitigation of 340B
Issues related to 340B Rebate Model Pilot Program for IRA compliance
Issues related to the US manufacturing of pharmaceuticals
Issues related to the development of novel therapies including cell therapy and antibody drug conjugates (ADCs)
Issues related to the recruitment of patients for clinical trials
Issues related to most-favored nations drug pricing proposals
General issues related to rare disease and orphan drugs
Policies related to international reference pricing for pharmaceuticals
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katie |
Jones |
|
|
|
Sarah |
Arbes |
|
|
|
Caroline |
Quat |
|
|
|
Lisa |
Langenderfer |
|
|
|
Taleen |
Mekhdjavakian |
|
Senator Bill Nelson, FL:
Staff Assistant: 2010-2012
Scheduler: 2013-2015
Legislative Correspondent: 2015-2016
Legislative Aide: 2016-2018 |
|
Bailey |
McCue |
|
Senator Cory Gardner - Intern, January 2019-May 2019, Legislative Correspondent, January 2020-January 2021
Senator John Cornyn - Legislative Aide April 2022-December 2022
Senator John Boozman - Legislative Assistant, December 2022-February 2025 |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 9599 The SECURE 340B Act
Pharmaceutical supply chain manufacturing
Policies related to the use of international reference pricing in Medicare/Medicaid
340B rebate model
Part B and Part D drugs
Medicare drug price negotiation
Medicare Part D reform
Definition of Qualified Single Source Drug (QSSD) for purposes of Medicare drug price negotiation
Medicare patient access to cancer screening
Medicare patient access to rare disease therapies
Centers for Medicare and Medicaid Innovation (CMMI) policy issues
Value-based payment arrangements
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katie |
Jones |
|
|
|
Caroline |
Quat |
|
|
|
Lisa |
Langenderfer |
|
|
|
Sarah |
Arbes |
|
|
|
Taleen |
Mekhdjavakian |
|
Senator Bill Nelson, FL:
Staff Assistant: 2010-2012
Scheduler: 2013-2015
Legislative Correspondent: 2015-2016
Legislative Aide: 2016-2018 |
|
Bailey |
McCue |
|
Senator Cory Gardner - Intern, January 2019-May 2019, Legislative Correspondent, January 2020-January 2021
Senator John Cornyn - Legislative Aide April 2022-December 2022
Senator John Boozman - Legislative Assistant, December 2022-February 2025 |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Pharmaceutical pricing negotiations
Implementation of One Big Beautiful Bill Act law (corporate minimum tax, R&D expensing)
Pharmaceutical manufacturing (general education)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katie |
Jones |
|
|
|
Caroline |
Quat |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
Issues related to patents and intellectual property
Patent/IP protections needed for medicines
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Caroline |
Quat |
|
|
|
Katie |
Jones |
|
|
|
Bailey |
McCue |
|
Senator Cory Gardner - Intern, January 2019-May 2019, Legislative Correspondent, January 2020-January 2021
Senator John Cornyn - Legislative Aide April 2022-December 2022
Senator John Boozman - Legislative Assistant, December 2022-February 2025 |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAR
16. Specific lobbying issues
Tax proposals building on One Big Beautiful Bill Act law and implementation (R&D expensing, BEAT, FDII, Corporate Alternative Minimum Tax)
HR 591 - Defending American Jobs and Investment Act
HR 1414 - Camerons Law, to restore orphan drug research tax credit
HR 1911 - To amend the Internal Revenue Code of 1986 to provide that certain payments to foreign related parties subject to sufficient foreign tax are not treated as base erosion payments
HR 1990 - American Innovation and R&D Competitiveness Act of 2025
S.1605 - International Competition for American Jobs Act
S.1639 - American Innovation and Jobs Act
S.3841 - Last Sale Valuation Act of 2026
Issues related to a Most Favored Nations policy in Medicare and Medicaid
Issues related to the renewable energy tax credits and other energy credits included in the Inflation Reduction Act
Most Favored Nations and pharmaceutical R&D innovation
Most Favored Nation drug pricing proposals
Pharmaceutical investment and pricing issues in ex-US countries
US trade tools (investigations, tariffs, trade agreements, congressional oversight, rules of origin, CBP enforcement, investment screening)
US-Mexico-Canada trade agreement (USMCA)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katie |
Jones |
|
|
|
Sarah |
Arbes |
|
|
|
Bailey |
McCue |
|
Senator Cory Gardner - Intern, January 2019-May 2019, Legislative Correspondent, January 2020-January 2021
Senator John Cornyn - Legislative Aide April 2022-December 2022
Senator John Boozman - Legislative Assistant, December 2022-February 2025 |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
Tax proposals building on One Big Beautiful Bill Act law and implementation (R&D expensing, BEAT, FDII, Corporate Alternative Minimum Tax)
Most Favored Nations and pharmaceutical R&D innovation
Most Favored Nation drug pricing proposals
US trade tools (investigations, tariffs, trade agreements, congressional oversight, rules of origin, CBP enforcement, investment screening)
US-Mexico-Canada trade agreement (USMCA)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katie |
Jones |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Work Opportunity Tax Credit renewal
Support for federal and state workforce programs (grants, technical assistance, partnership with federal and state agencies)
Support for federally registered apprenticeship programs
Support for manufacturing workforce development
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, U.S. Trade Representative (USTR), Commerce - Dept of (DOC), Treasury - Dept of, Labor - Dept of (DOL)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Katie |
Jones |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Tax proposals building on One Big Beautiful Bill Act law and implementation (R&D expensing, BEAT, FDII, Corporate Alternative Minimum Tax)
Tariffs/trade policies related to tariffs on pharmaceuticals
Issues related to the renewable energy tax credits and other energy credits included in the Inflation Reduction Act
HR 591 - Defending American Jobs and Investment Act
HR 1414 - Camerons Law, to restore orphan drug research tax credit
HR 1990 - American Innovation and R&D Competitiveness Act of 2025
HR 1911 - To amend the Internal Revenue Code of 1986 to provide that certain payments to foreign related parties subject to sufficient foreign tax are not treated as base erosion payments
S 1605 - International Competition for American Jobs Act
S 1639 - American Innovation and Jobs Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lisa |
Langenderfer |
|
|
|
Katie |
Jones |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |